However, no statistically notable discrepancy was observed in AMH levels between PCOS mothers’ neonates and healthy mothers’ neonates in the subgroup of male neonates (SMD =0.60; 95% CI = [−0.11, 1.31]), groups of European mothers (SMD =0.08; 95% CI = [−0.14, 0.30]), diagnosed by the Rotterdam criteria (SMD =0.08; 95% CI = [−0.14, 0.30]), and with a maternal BMI <30 kg/m2 (SMD =0.22; 95% CI = [−0.09, 0.54]). This evidence concerns the gene AMH and polycystic ovary syndrome.